Which GLP-1 Causes the Least Muscle Loss? What the Evidence Actually Says (2026)

Which GLP-1 causes the least muscle loss?

No randomized head-to-head trial has compared muscle or lean-mass loss between GLP-1 drugs, so there is no evidence-backed “winner” on this specific question. Any page that names one is going beyond what the trials support.

What exists are separate body-composition sub-studies of individual drugs, measured with different methods on different populations — which means you cannot validly line them up as “Drug A loses X% muscle, Drug B loses Y%.” The more useful finding, consistent across the evidence, is that lean-mass loss tracks the total amount and speed of weight lost, and is influenced far more by protein intake and resistance training than by which GLP-1 you take.

Which GLP-1 medication causes the least muscle loss?
No head-to-head trial has compared lean-mass loss between GLP-1 drugs, so there’s no evidence-based answer — any page naming one is overstating the data. Lean-mass loss tracks the total amount and speed of weight lost, and is influenced far more by protein intake and resistance training than by which GLP-1 you use.

What do the body-composition studies actually show?

Each drug has its own DXA (body-scan) sub-study, and both show that a meaningful share of weight lost is lean mass — as it is with almost any substantial weight loss:

• Tirzepatide (SURMOUNT-1 DXA sub-study): at 72 weeks, fat mass fell about 34% and lean mass about 11%, with lean mass making up roughly a quarter of total weight lost.
• Semaglutide (STEP 1 exploratory DXA analysis): total fat mass fell about 19% and lean mass about 10%, with the proportion of lean mass to total body mass actually increasing modestly.

These come from different trials with different DXA methods and populations, so the percentages are not directly comparable — reading them as a ranking would be a mistake. What they share is the real message: substantial weight loss includes lean mass, which is why protecting it is worth active effort.

How much muscle do you lose on a GLP-1?
In trial body-composition sub-studies, lean mass made up a meaningful share of total weight lost — roughly a quarter in the tirzepatide SURMOUNT-1 sub-study, with semaglutide’s STEP 1 analysis showing lean mass as a share of body mass slightly increasing. These come from separate trials and aren’t directly comparable, but both show substantial weight loss includes lean mass.

How much protein do I actually need on a GLP-1?

Obesity-medicine guidance during active weight loss commonly points to roughly 1.2–1.6 grams of protein per kilogram of body weight per day (using actual or adjusted body weight), with some guidance describing ranges up to about 2.0 g/kg. The goal on a GLP-1 is specifically adequacy: appetite suppression can make it easy to under-eat protein, which is exactly when lean mass is most at risk.

A 2025 multi-society advisory from the Obesity Medicine Association (OMA) and The Obesity Society (TOS) on nutrition during GLP-1 therapy emphasizes adequate protein and resistance training to preserve lean mass, though it frames this as a priority rather than fixing one universal number. The practical read: prioritize protein at each meal and treat a specific gram target as something to set with your clinician or a dietitian for your body and goals.

How much protein should I eat on a GLP-1?
Obesity-medicine guidance during weight loss commonly cites about 1.2–1.6 g of protein per kg of body weight per day (some guidance up to ~2.0 g/kg), using actual or adjusted body weight. On a GLP-1 the priority is adequacy, since appetite suppression makes under-eating protein easy. Set a specific target with your clinician or a dietitian.

Do I need to lift weights on a GLP-1 to keep muscle?

Resistance training is the best-evidenced way to protect lean mass during weight loss. A systematic review and meta-analysis of resistance training during caloric restriction found it prevented the large majority of the muscle loss that dieting otherwise causes. That evidence isn’t GLP-1-specific, but the mechanism — weight loss threatens lean mass, resistance training defends it — applies directly.

You don’t necessarily need a gym or heavy barbells; the principle is progressive resistance for the major muscle groups, at a level appropriate to your health and fitness. Anyone with cardiac issues, joint problems, or other limitations should clear an exercise plan with a clinician first.

Does lifting weights prevent muscle loss on a GLP-1?
It’s the best-evidenced protection. A meta-analysis of resistance training during caloric restriction found it prevented the large majority of diet-induced muscle loss. The evidence isn’t GLP-1-specific, but the mechanism applies directly. Progressive resistance for the major muscle groups, at a level suited to your health, is the goal — clear it with a clinician if you have limitations.

Can I still lose muscle even if I eat enough protein?

Yes — protein adequacy reduces lean-mass loss but doesn’t eliminate it, especially with rapid or large weight loss, older age, or without resistance training. Protein supplies the building blocks; resistance training provides the signal to keep the muscle. The two together are far more protective than either alone, and neither fully prevents some lean-mass change during substantial weight loss.

The takeaway isn’t to avoid weight loss — it’s to pair it with adequate protein and resistance training, and to judge progress by strength and function, not the scale alone.

Can I lose muscle on a GLP-1 even with enough protein?
Yes — adequate protein reduces lean-mass loss but doesn’t eliminate it, especially with rapid or large weight loss, older age, or no resistance training. Protein supplies the building blocks and resistance training provides the signal to keep muscle; together they’re far more protective than either alone, though some lean-mass change is normal with substantial weight loss.

When should I raise muscle loss with my prescriber?

Worth raising if you’re losing weight very fast, noticing weakness or a drop in strength, are older, or can’t hit adequate protein because of appetite suppression. A clinician may check that your rate of loss is appropriate, adjust the plan, or refer you to a dietitian; a body-composition scan (DXA) can distinguish fat loss from lean-mass loss if that’s a concern.

Where does the provider choice come in?

Since no GLP-1 is proven to spare muscle more than another, the provider decision is better made on the things that are established — the medication that fits your clinical picture, side-effect tolerance, and cost. A prescriber weighs those; a good program supports the protein-and-training side alongside the medication.

For the medication comparison itself, see semaglutide vs. tirzepatide; for what programs actually cost, the GLP-1 Price Index. Both keep the decision on evidence rather than an unproven muscle-sparing claim.